Active substance
|
Sensitising concentration in human (HRIPT)
|
Sensitising concentration in animal testing (LLNA)
|
Concentration of application
|
---|
| | |
Cleaning & washing
|
Cosmetics
|
Home improvement
|
---|
CMI/MI
|
12.5 ppm [26](challenge conc. 12.5 ppm)
|
75 ppm (EC3) [27]
|
≤ 60 ppm
|
2.5 - 7.5 ppm (15 ppma)
| |
Glutardialdehyde
|
5% [28](challenge conc. 0.5%)
|
0.1% (EC3) [29]
|
0.01 - 0.5%
|
≤ 0.1% (0.1%a)
| |
Formaldehyde
|
1% [28](challenge conc. 1%)
|
0.35% (EC3) [30]
|
≤ 0.05%
|
≤ 0.2% (0.2%a)
|
≤ 0.1%
|
Bronopol
|
5% [28](challenge conc. 2.5%)
| |
0.0011 - 0.035%
|
0.01 - 0.1% (0.1%a)
|
0.0011 - 0.035%
|
Chloroacetamide
|
0.5% [31](challenge conc. 0.5%)
| |
0.1 - 0.3%
|
≤ 0.3% (0.3%a)
|
0.1 - 0.3%
|
- CMI/MI = mixture of 5-chloro-2-methyl-2H-isothiazolin-3-one and 2-methyl-2H-isothiazolin-3-oneHRIPT: Human Repeat Insult Patch test
- LLNA: Local lymph node assay
- EC3: concentration leading to a triplicate proliferation rate in the Local lymph node assay.
- a = max. value of cosmetics directive [17]